Acute Stress Disorder vs. Post-Traumatic Stress Disorder

The human confrontation with overwhelming psychological trauma induces profound neurobiological, cognitive, and affective perturbations that challenge baseline evolutionary homeostasis. When individuals encounter catastrophic events—such as life-threatening physical assaults, vehicular collisions, combat exposure, natural disasters, or sexual violence—the central nervous system deploys complex survival circuits mediated by the sympathetic-adreno-medullary axis and the hypothalamic-pituitary-adrenal network. While transient acute stress reactions reflect an adaptive, phylogenetically conserved survival repertoire, the trajectory of post-traumatic psychological morbidity frequently diverges into distinct pathological states. Within psychiatric nosology, the distinction between acute, short-term trauma sequelae and persistent, chronic neurobehavioral syndromes forms the clinical frontier separating Acute Stress Disorder from Post-Traumatic Stress Disorder.

Historically conceptualized along a temporal continuum of post-traumatic psychopathology, Acute Stress Disorder and Post-Traumatic Stress Disorder represent distinct diagnostic constructs with unique structural architectures, clinical criteria, prognostic implications, and therapeutic indications. The diagnostic categorization established by modern classification systems, particularly the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), reflects decades of clinical debate regarding whether early psychological distress constitutes a normal, transient stress reaction, a discrete psychiatric illness, or a prodromal marker for intractable chronicity. Clinicians and psychiatric researchers are charged with identifying when immediate peritraumatic distress transitions into pathological neurocircuitry remodeling, requiring targeted early intervention to prevent severe long-term functional impairment.

Understanding the delicate boundary between acute post-traumatic distress and enduring traumatic psychopathology requires examining neurobiological mechanisms, diagnostic thresholds, epidemiological divergence, and psychotherapeutic paradigms. As psychiatric clinical practice increasingly embraces trauma-informed care and precision neurobiology, distinguishing Acute Stress Disorder from Post-Traumatic Stress Disorder is not merely an academic exercise in nosological classification; it is a clinical necessity that directly dictates patient safety, the timing of psychotherapeutic interventions, the avoidance of iatrogenic pharmacological harm, and long-term psychosocial recovery. This comprehensive analysis evaluates both conditions, detailing their historical origins, neurobiological signatures, diagnostic rules, clinical divergence, and therapeutic management.

1. Introduction to Trauma-Related Stress Conditions

1.1 Defining Acute Stress Disorder and Post-Traumatic Stress Disorder

Acute Stress Disorder (ASD) and Post-Traumatic Stress Disorder (PTSD) are clinically recognized psychiatric conditions categorized under the broad umbrella of Trauma- and Stressor-Related Disorders in modern psychiatric classification systems. At its conceptual foundation, Acute Stress Disorder represents an acute, severe psychological and neurobiological reaction that emerges in the immediate wake of an overwhelming, life-threatening, or catastrophic event. To meet formal clinical thresholds, ASD requires that symptoms develop within days of trauma exposure and endure for a finite period lasting from a minimum of three days up to a maximum of one month. The disorder captures a state of multidimensional destabilization, characterized by an acute convergence of involuntary intrusive re-experiencing, pervasive negative alterations in mood, dissociative disruptions, extensive behavioral avoidance, and severe autonomic hyperarousal. These manifestations reflect an intense failure of the individual’s baseline neurocognitive allostasis to restore physiological equilibrium immediately following exposure to critical incidents.

Conversely, Post-Traumatic Stress Disorder represents an enduring, chronic, and frequently debilitating neuropsychiatric syndrome characterized by the persistent consolidation and pathological entrenchment of traumatic memories and threat-related neurocircuitry. Unlike ASD, PTSD is diagnosed only when diagnostic symptoms persist for longer than one full month following the traumatic event, with clinical presentations often lasting months, years, or decades in the absence of evidence-based intervention. PTSD represents not merely an elongation of acute distress, but a structural remodeling of fear-extinction learning mechanisms, neuroendocrine dysregulation, and persistent alterations in self-referential cognitive schemas. While ASD was conceptualized in large part to identify acute, short-term crisis reactions and capture individuals at elevated risk of long-term impairment, PTSD captures the chronic, consolidated manifestation of post-traumatic psychopathology, characterized by structural and functional alterations within corticolimbic circuits.

From an evolutionary perspective, acute psychological and physiological distress following exposure to catastrophic life events serves an adaptive, protective function. The acute mobilization of fear, persistent vigilance, intrusive cognitive processing of survival-critical environmental cues, and temporary avoidance of threat-associated stimuli historically enhanced the survival of ancestral organisms operating in high-threat environments. However, when these neurobiological defense systems fail to undergo natural extinction and down-regulation once immediate environmental safety has been re-established, the acute adaptive response transforms into a maladaptive psychiatric condition. The differentiation between an immediate, transient stress response and a persistent psychiatric condition rests upon the chronological duration of symptoms, the structural configuration of symptom domains, and the degree to which neurocognitive and psychosocial functioning becomes chronically compromised.

1.2 Historical Context and Nosological Evolution in DSM and ICD

The historical evolution of post-traumatic nosology reflects shifts in societal, military, and psychiatric paradigms over the past century. Prior to the formal codification of trauma-related diagnostic entities in standard nomenclature, clinical presentations of acute and chronic post-traumatic distress were documented under military and historical terms such as “railway spine” during the Industrial Revolution, “shell shock” during World War I, and “combat neurosis” or “gross stress reaction” during World War II. The formalization of Post-Traumatic Stress Disorder occurred in 1980 with the publication of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). This inclusion was driven by the collaborative advocacy of psychiatric researchers, such as Robert Jay Lifton, Chaim Shatan, and Mardi J. Horowitz, whose 1976 formulation of Stress Response Syndromes provided the alternating intrusion-denial conceptual framework. These researchers worked in tandem with clinical advocates treating Vietnam War combat veterans and civilian survivors of sexual assault and catastrophic disasters, creating a unified diagnosis recognizing that catastrophic external events could produce lasting psychiatric pathology.

In contrast, Acute Stress Disorder was introduced significantly later, making its debut in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) in 1994. The primary nosological impetus behind the introduction of ASD was twofold: first, to establish a formal diagnostic framework for capturing acute, clinically significant psychological distress occurring within the initial month following trauma exposure; and second, to serve as a predictive diagnostic filter capable of identifying vulnerable individuals at high risk for subsequently developing chronic PTSD. In the DSM-IV framework, ASD heavily emphasized peritraumatic dissociative symptoms, such as depersonalization, derealization, dissociative amnesia, and a reduction in awareness of surroundings, based on early empirical hypotheses suggesting that peritraumatic dissociation represented the primary predictor of chronic post-traumatic pathology.

The contemporary psychiatric landscape reveals divergent categorizations across major international classification systems, notably between the DSM-5-TR and the World Health Organization’s (WHO) International Classification of Diseases, Eleventh Revision (ICD-11). In the DSM-5 and its text revision (DSM-5-TR), ASD is classified as a formal acute mental disorder within the Trauma- and Stressor-Related Disorders chapter, having abandoned the absolute requirement for dissociative symptoms in favor of a flexible, polythetic symptom pool requiring at least nine of fourteen symptoms across five diagnostic categories. In contrast, the ICD-11 adopted a fundamentally different nosological stance by removing Acute Stress Disorder from its classification of mental, behavioral, or neurodevelopmental disorders entirely. Instead, the ICD-11 classifies Acute Stress Reaction (ASR) under Factors influencing health status or contact with health services (Code QE84). The WHO conceptualizes acute post-traumatic distress as a transient, non-pathological, and normative physiological and psychological response to exceptional physical or mental stress that typically subsides within days without developing into a formal psychiatric disorder, thereby aiming to minimize the risk of over-pathologizing normative human distress.

1.3 Why ASD and PTSD Are Frequently Conflated in Practice

Despite their distinct temporal parameters and structural differences in modern psychiatric manuals, Acute Stress Disorder and Post-Traumatic Stress Disorder are frequently conflated by clinicians, emergency room personnel, primary care practitioners, and mental health professionals. This confusion stems from their substantial phenomenological overlap. Both conditions are triggered by exposure to an identical threshold of traumatic severity (Criterion A events) and share core psychological manifestations: distressing intrusive recollections, traumatic nightmares, intense psychological and physiological cue reactivity, persistent behavioral avoidance of trauma reminders, generalized hypervigilance, and exaggerated autonomic startle responses. When an acutely traumatized patient presents with profound agitation, sleep disruption, and tearful re-experiencing shortly after an event, distinguishing between early acute distress and early-stage chronic trauma pathology is clinically difficult without careful longitudinal tracking.

Furthermore, widespread misconceptions regarding the strict temporal boundaries separating both diagnoses contribute to clinical conflation. Many clinicians fail to recognize the mandatory 72-hour exclusion rule embedded within DSM-5-TR diagnostic criteria for ASD: an individual cannot receive a formal diagnosis of ASD during the first 72 hours immediately following the traumatic incident, regardless of how intense their acute distress may be. During this initial 72-hour window, symptoms are classified as normative peritraumatic distress or acute stress reactions. Clinicians frequently misapply the label of ASD to individuals within hours of an incident, or inappropriately diagnose PTSD prior to the mandatory 30-day post-trauma threshold. This temporal misapplication obscures epidemiological research and distorts prognostic counseling, creating unnecessary distress for patients who may experience spontaneous symptom remission once baseline safety is restored.

Clinical complexities are further exacerbated when acute post-traumatic distress presents without formal dissociative manifestations. Historically, clinicians relied on prominent dissociative signs—such as trance-like detachment, fugue states, or severe derealization—to conceptually anchor a presentation as Acute Stress Disorder. Because the DSM-5-TR eliminated the absolute requirement for dissociative features, allowing patients to qualify for an ASD diagnosis based solely on non-dissociative combinations of intrusive memories, hyperarousal, and avoidance, the overt clinical presentation of ASD can mirror that of classic PTSD. Consequently, without taking a rigorous timeline history, practitioners can easily mistake an acute, self-limiting stress presentation for long-standing PTSD, or fail to initiate secondary prevention interventions designed specifically to arrest the progression of ASD into chronic pathology.

2. Overview of Acute Stress Disorder (ASD)

2.1 Etiological Triggers and Criterion A Exposures

The initiation of Acute Stress Disorder requires exposure to an identifiable, catastrophic stressor defined under the rigorous boundaries of Criterion A in the DSM-5-TR. Criterion A establishes that the qualifying event must involve actual or threatened death, serious physical injury, or sexual violence. The operational scope of this exposure encompasses four distinct pathways: direct personal experience of the catastrophic incident; in-person witnessing of the event as it occurs to others; learning that a traumatic event occurred to an immediate family member or close personal friend (with the strict caveat that the event must have been violent or accidental in nature); or experiencing repeated or extreme indirect exposure to aversive, gruesome details of the event during the execution of professional occupational duties (such as first responders collecting human remains or police officers repeatedly exposed to details of child abuse). Crucially, the diagnostic criteria explicitly stipulate that indirect exposure through electronic media, television, movies, or photographs does not qualify under Criterion A unless directly work-related.

The immediate physiological and psychological shock response following critical incident exposure involves a coordinated neuroendocrine defense cascade. The sensory perception of catastrophic danger triggers immediate hyperactivation of the brainstem and limbic nuclei, initiating rapid sympathetic discharges that elevate heart rate, increase systemic blood pressure, induce hyperventilation, and cause peripheral vasoconstriction. Concurrently, the psychological shock response frequently manifests as acute disorientation, cognitive constriction, emotional numbness, or an overwhelming sense of helplessness. In high-threat circumstances, this response shifts cognitive processing away from analytical, reflective thought toward primitive survival behaviors aimed at fight, flight, or behavioral freezing.

Vulnerability to developing Acute Stress Disorder following a Criterion A event is not uniformly distributed across the population. A multitude of pre-existing and peritraumatic risk factors mediate an individual’s susceptibility to acute psychological collapse. Pre-existing psychiatric vulnerability, particularly a prior personal history of depressive disorders, anxiety disorders, or earlier unresolved traumatic events, significantly lowers the neurobiological threshold for acute decompensation. Demographically, female sex and younger age at exposure have been identified as modest risk factors across several epidemiological cohorts. However, among the most robust predictors of ASD development is the phenomenon of severe peritraumatic dissociation occurring during or immediately following the traumatic event. When individuals experience profound alterations in temporal perception, depersonalization, or out-of-body sensations during the trauma itself, the psychological encoding of the experience becomes fragmented, impairing cognitive integration and predisposing the neurocognitive system to severe post-exposure decompensation.

2.2 Diagnostic Criteria According to DSM-5-TR

The diagnostic framework for Acute Stress Disorder within the DSM-5-TR departs from the cluster-specific mandates characteristic of PTSD by implementing a broad, polythetic symptom pool. Under Criterion B, a patient must exhibit at least nine out of fourteen operationalized symptoms across five distinct functional categories: intrusion, negative mood, dissociation, avoidance, and arousal. These symptoms must have their onset or undergo marked exacerbation following the traumatic exposure. The specific symptoms comprising this diagnostic pool encompass the following clinical manifestations:

• Intrusion Symptoms:
  • Recurrent, involuntary, and intrusive distressing memories of the traumatic event.
  • Recurrent distressing dreams in which the content and/or affect of the dream are related to the event.
  • Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event were recurring, ranging along a continuum up to a complete loss of situational awareness.
  • Intense or prolonged psychological distress, or marked physiological reactivity, in response to internal or external cues that symbolize or resemble an aspect of the traumatic event.
• Negative Mood:
  • Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction, or loving feelings).
• Dissociative Symptoms:
  • An altered sense of the reality of one’s surroundings or of oneself (e.g., seeing oneself from the perspective of another, being in a daze, time slowing down).
  • Inability to remember an important aspect of the traumatic event (typically dissociative amnesia, not attributable to head injury, alcohol, or substance intoxication).
• Avoidance Symptoms:
  • Efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event.
  • Efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about the event.
• Arousal Symptoms:
  • Sleep disturbance (e.g., difficulty falling or staying asleep, or restless, fragmented sleep).
  • Irritable behavior and angry outbursts (with little or no provocation), typically expressed as verbal or physical aggression toward people or objects.
  • Hypervigilance directed toward detecting potential threats.
  • Problems with concentration and focus on routine cognitive tasks.
  • Exaggerated startle response to sudden, benign sensory stimuli.

Crucially, Criterion C establishes the strict temporal parameter governing the diagnosis: the duration of the disturbance must range between a minimum of three days and a maximum of one month following trauma exposure. If symptoms emerge within the initial 48 to 72 hours but completely resolve by day three, an ASD diagnosis cannot be assigned. Criterion D mandates that the disturbance cause clinically significant distress or impairment in social, occupational, or other critical domains of functioning. Finally, Criterion E serves as an essential diagnostic exclusion rule, requiring that the symptoms are not attributable to the direct physiological effects of a substance (such as alcohol withdrawal, prescription medication toxicity, or illicit drug intoxication) or another general medical condition (such as traumatic brain injury or post-concussive syndrome).

2.3 Neurobiological Mechanisms in the Acute Post-Trauma Phase

The acute post-trauma phase is characterized by rapid, transient perturbations within central and peripheral neurobiological circuits, reflecting an acute breakdown in fear regulation. Central to this acute pathophysiology is transient hyperactivation within the limbic system, particularly the basolateral complex of the amygdala. The amygdala acts as the central alarm system of the brain, processing sensory representations of environmental threats and executing rapid behavioral defense responses through projections to the hypothalamus and brainstem. In the acute aftermath of traumatic shock, sensory inputs linked to the trauma trigger hyper-reactive amygdaloid firing, provoking surges of autonomic catecholamines, notably norepinephrine and epinephrine, via the locus coeruleus and sympathetic nerve terminals. This persistent adrenergic cascade sustains autonomic hyperarousal, manifesting clinically as tachycardia, diaphoresis, pupillary dilation, and heightened motoric tension.

Concurrently, the regulatory neurocircuitry responsible for inhibiting subcortical fear structures experiences acute functional disruption. Under normal homeostatic conditions, the medial prefrontal cortex (mPFC)—including the ventromedial prefrontal cortex (vmPFC) and the anterior cingulate cortex (ACC)—exerts top-down inhibitory control over amygdaloid reactivity via dense networks of inhibitory gamma-aminobutyric acid (GABA) interneurons. In the acute wake of severe trauma, excessive catecholaminergic and glutamatergic signaling temporarily disrupts mPFC functioning. This acute prefrontal hypoactivation diminishes top-down executive restraint, releasing the amygdala from normative cognitive inhibition. Consequently, benign trauma-related sensory stimuli escape cognitive filtering and trigger unmodulated fear cascades, manifesting as intrusive recollections, pervasive hypervigilance, and exaggerated startle responses.

At the neuroendocrine level, the hypothalamic-pituitary-adrenal (HPA) axis undergoes dynamic peritraumatic dysregulation. In response to extreme stress, the paraventricular nucleus of the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), ultimately triggering the release of cortisol from the adrenal cortex. Cortisol typically serves to mobilize energy reserves, suppress non-essential physiological processes, and exert negative feedback control over the hypothalamus and pituitary to shut down the stress response once danger subsides. In the acute post-trauma phase, distinct alterations emerge: while some acutely traumatized individuals exhibit elevated cortisol concentrations reflecting acute systemic stress, individuals vulnerable to persistent post-traumatic psychopathology often present with blunted, hypocortisolemic baseline profiles or heightened glucocorticoid receptor sensitivity. This relative insufficiency of circulating glucocorticoids impairs the natural termination of adrenergic hyperactivation, permitting unconstrained catecholaminergic tone to persist and facilitating the pathological consolidation of traumatic fear memories.

2.4 Prognosis and Risk of Trajectory Toward Chronicity

The natural history and longitudinal trajectory of Acute Stress Disorder are characterized by significant clinical heterogeneity. Extensive empirical investigations evaluating trauma survivors demonstrate that a substantial proportion of individuals diagnosed with ASD experience spontaneous symptom remission within the first four weeks post-exposure. Natural psychological resilience mechanisms, restoration of physical safety, activation of familial and community support systems, and natural cognitive processing contribute to the rapid down-regulation of acute autonomic hyperarousal and the gradual extinction of acute fear reactions. In these resilient cohorts, the acute symptom profile represents a transient, self-limiting post-traumatic crisis that resolves without progressing into chronic structural psychopathology.

However, empirical conversion rates indicate that Acute Stress Disorder carries substantial prognostic risk for the development of chronic Post-Traumatic Stress Disorder. Longitudinal studies indicate that approximately 50% of individuals who meet formal diagnostic criteria for ASD subsequently meet the diagnostic threshold for PTSD at one, three, and six months post-trauma. The presence of full-syndrome ASD within the initial month serves as one of the strongest individual clinical risk factors for chronicity, signifying that the acute neurocognitive and autonomic disruption has failed to achieve homeostatic resolution. Patients who present with high baseline symptom density, severe peritraumatic dissociative features, persistent sleep disruption, and pervasive avoidance behaviors are at elevated risk for chronic functional impairment.

Conversely, epidemiological research highlights a critical limitation in the prognostic utility of ASD: a substantial proportion of individuals who ultimately develop chronic PTSD do not meet the full diagnostic criteria for ASD during the initial month. Many future PTSD patients present acutely with sub-threshold or milder stress reactions that gradually escalate over subsequent months, or exhibit delayed-onset presentations following secondary life stressors. Thus, while an ASD diagnosis is highly predictive of future psychiatric vulnerability, its absence does not ensure immunity against chronic post-traumatic pathology. Early clinical non-responders—individuals whose acute symptoms show no attenuation by the third or fourth week post-trauma—represent a high-priority clinical population requiring immediate, stepped-care psychological interventions to intercept the trajectory toward chronic PTSD.

3. Overview of Post-Traumatic Stress Disorder (PTSD)

3.1 Etiological Framework and Pathological Memory Consolidation

Post-Traumatic Stress Disorder represents a chronic, complex neurobehavioral condition arising from a profound breakdown in the brain’s capacity to process, contextualize, and extinguish traumatic memories. Within an etiological framework, PTSD is conceptualized as a disorder of pathological memory consolidation and impaired fear extinction. During exposure to a life-threatening Criterion A event, elevated concentrations of catecholamines, stress hormones, and glutamate flood the central nervous system, creating an ideal neurochemical environment for the over-consolidation of traumatic memories within subcortical structures. The memory trace of the traumatic incident is encoded not as an integrated, narrative autobiographical memory with temporal and spatial parameters, but as fragmented, sensorimotor representations that remain hypersensitive to benign environmental triggers.

Central to this chronic memory pathology are profound deficits in contextual processing, primarily mediated by structural and functional alterations within the hippocampus. The hippocampus is responsible for binding sensory stimuli to specific spatial and temporal contexts, allowing the brain to distinguish past danger from present safety. In individuals with PTSD, hippocampal contextualization mechanisms are compromised, preventing the neurocognitive system from recognizing that the traumatic event has concluded. Consequently, when an individual encounters sensory cues that bear superficial resemblance to the original trauma—such as the smell of diesel, a sudden auditory blast, or a specific environmental temperature—the brain fails to apply contextual inhibition. Instead, the subcortical fear network retrieves the uncontextualized traumatic memory trace, generating unprompted, involuntary intrusive recollections and terrifying flashback states where the event is experienced as occurring in the immediate present.

The etiological development of PTSD is further compounded by the cumulative burden of traumatic exposures over the lifespan. While a single, acute catastrophic event (such as an industrial explosion or a motor vehicle collision) can produce classical PTSD, the risk of developing chronic, treatment-resistant post-traumatic pathology rises exponentially with repeated, prolonged, or interpersonal trauma exposures. Interpersonal traumas, such as prolonged childhood physical or sexual abuse, domestic captivity, or systematic combat exposure, inflict severe damage upon cognitive schemas relating to trust, safety, autonomy, and self-worth. This repetitive traumatization results in cumulative allostatic load, remodeling the physiological stress-response architecture and producing deep-seated alterations in neurocircuitry that resist spontaneous recovery.

3.2 Four Diagnostic Clusters in Modern Psychiatric Manuals

The diagnostic architecture of Post-Traumatic Stress Disorder underwent significant structural refinement with the publication of the DSM-5 and DSM-5-TR, transitioning from the historic three-cluster model of DSM-IV into a robust, four-cluster operational framework. To satisfy a formal diagnosis of PTSD, an individual must have experienced a qualifying Criterion A exposure, and their symptoms must endure for more than one full month (Criterion F), while causing clinically significant impairment in social, occupational, or other functional domains (Criterion G), without being attributable to substances or medical conditions (Criterion H). The four mandatory symptom clusters are categorized as follows:

• Cluster B: Intrusion Symptoms (At least 1 of 5 required):
  • Recurrent, involuntary, and intrusive distressing memories of the traumatic event.
  • Recurrent distressing dreams in which the content and/or affect of the dream are related to the event.
  • Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event were recurring.
  • Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event.
  • Marked physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event.
• Cluster C: Persistent Avoidance (At least 1 of 2 required):
  • Avoidance of or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event.
  • Avoidance of or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the traumatic event.
• Cluster D: Negative Alterations in Cognitions and Mood (At least 2 of 7 required):
  • Inability to remember an important aspect of the traumatic event (typically dissociative amnesia).
  • Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., “I am bad,” “No one can be trusted,” “The world is completely dangerous”).
  • Persistent, distorted cognitions about the cause or consequences of the traumatic event that lead the individual to blame himself/herself or others.
  • Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame).
  • Markedly diminished interest or participation in significant activities.
  • Feelings of detachment or estrangement from others.
  • Persistent inability to experience positive emotions (e.g., inability to feel happiness, satisfaction, or loving feelings).
• Cluster E: Alterations in Arousal and Reactivity (At least 2 of 6 required):
  • Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or physical aggression toward people or objects.
  • Reckless or self-destructive behavior.
  • Hypervigilance directed toward the environment.
  • Exaggerated startle response.
  • Problems with concentration.
  • Sleep disturbance (e.g., difficulty falling or staying asleep, or restless sleep).

3.3 Pathophysiological Profile and Long-Term Neurocircuitry Changes

The pathophysiology of established Post-Traumatic Stress Disorder is defined by structural, functional, and neuroendocrine neurocircuitry remodeling. Neuroimaging investigations, including structural magnetic resonance imaging (MRI) and functional neuroimaging (fMRI and PET), have consistently identified a core triad of disrupted brain regions: the amygdala, the medial prefrontal cortex, and the hippocampus. In patients with established PTSD, the basolateral amygdala exhibits persistent, uncalibrated hyper-reactivity to threat-related stimuli. Concurrently, the ventromedial prefrontal cortex and the anterior cingulate cortex demonstrate significant gray matter volumetric reductions and functional hypoactivation, resulting in an enduring failure of top-down inhibitory control over subcortical fear structures. This corticolimbic dysregulation perpetuates a perpetual neurobiological state of perceived threat, preventing extinction learning.

Parallel to corticolimbic dysfunction, the hippocampus undergoes profound structural alterations. Volumetric neuroimaging studies have demonstrated significant reductions in bilateral hippocampal volume among individuals with chronic, long-standing PTSD. While clinical debate continues regarding whether diminished hippocampal volume represents a pre-existing neurodevelopmental vulnerability factor or an acquired neurotoxic consequence of chronic stress, empirical evidence indicates that sustained hypercortisolemia and sustained glutamatergic excitotoxicity induce dendritic atrophy, loss of synaptic spines, and reduced neurogenesis within the subgranular zone of the dentate gyrus. This structural compromise impairs hippocampal contextual gating, reinforcing intrusive re-experiencing and generalize threat perception across benign everyday environments.

At the neuroendocrine and immunological levels, PTSD displays a biological profile characterized by a paradoxically sensitized HPA axis coupled with chronic systemic inflammation. Unlike major depressive disorder, which is typically characterized by basal hypercortisolemia and glucocorticoid receptor resistance, established PTSD is frequently marked by sustained, low basal circulating cortisol concentrations paired with hyper-sensitized glucocorticoid receptor signaling in peripheral mononuclear cells. This heightened negative feedback sensitivity rapidly clears cortisol from systemic circulation while failing to restrain central corticotropin-releasing hormone (CRH) hypersecretion. Furthermore, chronic post-traumatic stress disrupts autonomic-immune balance, driving persistent low-grade systemic inflammation characterized by elevated circulating levels of pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP). This chronic pro-inflammatory state contributes to the high rates of somatic, cardiovascular, and autoimmune comorbidities observed in chronic PTSD populations.

3.4 Subtypes, Complex Presentations, and Chronic Course

The clinical presentation of Post-Traumatic Stress Disorder is marked by distinct diagnostic subtypes and dimensional complexities. In recognition of clinical variability, the DSM-5-TR delineates a specific Dissociative Subtype of PTSD. To qualify for this diagnostic specifier, an individual must satisfy the full diagnostic criteria for PTSD while simultaneously experiencing prominent, persistent dissociative manifestations that fall into two distinct domains: depersonalization (persistent or recurrent experiences of feeling detached from, and as if one were an outside observer of, one’s mental processes or body, such as feeling as though one were in a dream) or derealization (persistent or recurrent experiences of unreality of surroundings, such as the world appearing dreamlike, distant, or distorted). Neurobiologically, while classical PTSD is characterized by corticolimbic under-modulation (amygdala hyper-reactivity driven by prefrontal failure), the dissociative subtype exhibits corticolimbic over-modulation, characterized by excessive prefrontal inhibition that suppresses amygdalar activity, producing profound emotional detachment and depersonalization.

A second critical diagnostic specifier is the Delayed Expression specifier. This designation applies when the full diagnostic criteria for PTSD are not met until at least six months following the traumatic exposure, even though the onset of some individual symptoms may have occurred immediately or shortly after the incident. Delayed expression frequently occurs when individuals initially manage trauma through intense behavioral avoidance, high operational demands, or rigid social structures; once these external coping mechanisms or structures erode—such as following retirement, military discharge, or secondary life stressors—the underlying traumatic memories escape suppression, precipitating full clinical decompensation.

A major nosological development in international psychiatry is the conceptualization of Complex PTSD (CPTSD), officially formalized within the World Health Organization’s ICD-11. CPTSD is recognized as a distinct diagnostic entity that develops following exposure to traumatic events that are typically severe, prolonged, and difficult or impossible to escape (such as childhood abuse, domestic captivity, or sustained torture). In addition to the three core symptom domains of classical PTSD (re-experiencing in the present, avoidance of reminders, and persistent perception of current threat), CPTSD requires severe, pervasive disturbances in three domains of personality functioning, collectively referred to as Disturbances in Self-Organization (DSO): severe affective dysregulation (emotional hyper-reactivity or complete emotional numbness); persistent negative self-concept (entrenched feelings of worthlessness, shame, and deep failure); and severe relational impairment (persistent difficulties in sustaining interpersonal relationships and feeling close to others). Recognizing this distinct complex presentation is vital, as CPTSD requires comprehensive, multimodal treatment strategies extending beyond standard exposure protocols.

4. Key Differences Between ASD and PTSD

While Acute Stress Disorder and Post-Traumatic Stress Disorder share an identical Criterion A exposure baseline and extensive phenomenological overlap, they are separated by fundamental distinctions in their temporal parameters, diagnostic architectures, neurobiological trajectories, and treatment paradigms. To provide clinical clarity, the following head-to-head comparison table systematically contrasts both disorders across their primary clinical and nosological dimensions:

Diagnostic Dimension	Acute Stress Disorder (ASD)	Post-Traumatic Stress Disorder (PTSD)
Diagnostic Timing & Duration	Symptoms must emerge and persist between 3 days and 1 month post-trauma. Cannot be diagnosed within the first 72 hours.	Symptoms must persist for more than 1 month (Criterion F). Can emerge immediately or with delayed expression (≥6 months).
Diagnostic Architecture (DSM-5-TR)	Broad polythetic pool: requires at least 9 of 14 symptoms across 5 broad categories without mandatory cluster minimums.	Strict categorical thresholds: requires specific minimum symptom counts across four separate clusters (B, C, D, and E).
ICD-11 Classification	Not classified as a mental disorder. Categorized as “Acute Stress Reaction” (QE84), a transient, non-pathological response.	Formal mental disorder classified under Disorders Specifically Associated with Stress, alongside Complex PTSD.
Role of Dissociative Symptoms	Dissociative symptoms are part of the 14-symptom pool; not required for diagnosis, but historically prominent.	Dissociative amnesia is an option in Cluster D; formal dissociative features are captured via the specific Dissociative Subtype.
Underlying Neurocircuitry State	Acute, transient corticolimbic disruption; rapid catecholaminergic surges and fluctuating acute HPA axis activation.	Consolidated, chronic corticolimbic remodeling; hippocampal volumetric reduction, glucocorticoid receptor sensitization.
Spontaneous Remission Potential	High rate of spontaneous remission within the first 30 days as homeostatic resilience mechanisms engage.	Substantially lower rate of spontaneous remission; untreated PTSD frequently pursues a chronic, fluctuating, lifelong course.
Primary Treatment Paradigm	Crisis stabilization, Psychological First Aid (PFA), sleep monitoring, and brief early Trauma-Focused CBT (TF-CBT).	Comprehensive trauma reprocessing: Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), EMDR, and SSRIs.
Pharmacological Considerations	Pharmacotherapy generally discouraged; avoidance of benzodiazepines due to risk of impairing fear extinction.	FDA-approved SSRIs (sertraline, paroxetine); adjunctive prazosin for trauma-related nightmares and sleep disturbance.

4.1 Temporal Parameters: Onset, Duration, and Diagnostic Windows

The temporal framework separating Acute Stress Disorder from Post-Traumatic Stress Disorder represents the most definitive clinical boundary between the two conditions. Under DSM-5-TR criteria, the diagnostic window for Acute Stress Disorder opens strictly at 72 hours (Day 3) following exposure to a qualifying Criterion A traumatic event and closes precisely at the conclusion of one month (Day 30). This mandatory 72-hour exclusion rule was deliberately incorporated into modern psychiatric nosology to prevent the medicalization and pathologization of universal peritraumatic distress. In the initial hours and days following a severe life threat, transient disorientation, weeping, autonomic arousal, insomnia, and intrusive images represent expected, normative human physiological reactions to extraordinary circumstances. Only when these symptoms persist beyond three days, demonstrating a failure of immediate spontaneous settling, does the presentation meet the threshold for a clinical diagnosis of ASD.

Conversely, the diagnostic window for Post-Traumatic Stress Disorder requires that symptoms endure for more than one full month following traumatic exposure. When a patient with Acute Stress Disorder continues to display severe, impairing symptoms on Day 31 post-trauma, their diagnostic status undergoes a formal clinical transition: the diagnosis of ASD is retired, and a diagnosis of PTSD is assigned. PTSD encapsulates enduring psychopathology; once established, its natural course can extend across decades if appropriate trauma-focused treatment is not rendered. While the onset of PTSD symptoms is frequently immediate—emerging in the days following the event and persisting unabated—the diagnosis can also accommodate delayed presentations. Under the DSM-5-TR delayed expression specifier, the full diagnostic threshold may not be met until months or even years post-exposure, a diagnostic trajectory entirely unavailable within the bounded diagnostic rules of ASD.

These strict temporal parameters generate critical clinical decision-making imperatives for emergency departments, trauma centers, and community crisis clinics. Evaluating a survivor 24 hours after an industrial blast or sexual assault requires supportive crisis intervention, basic need assessment, and acute psychoeducation, but formal psychometric coding for ASD is clinically prohibited until the third day. Similarly, documenting an ASD diagnosis on a patient whose traumatic exposure occurred three months prior represents a diagnostic error, obscuring the chronicity of the presentation and potentially delaying the deployment of comprehensive trauma-focused psychotherapeutic regimens designed specifically for consolidated PTSD.

4.2 Diagnostic Architecture and Symptom Clustering Rules

Beyond temporal boundaries, the internal structural architecture of diagnostic criteria reveals deep conceptual differences between ASD and PTSD. The DSM-5-TR constructs Acute Stress Disorder using a unified, polythetic symptom pool. Rather than requiring clinicians to establish specific minimum symptom thresholds across separate cognitive, affective, and physiological domains, ASD aggregates fourteen operationalized symptoms across five areas (intrusion, negative mood, dissociation, avoidance, and arousal) into a single checklist. To qualify for a diagnosis of ASD, a patient must satisfy any nine of these fourteen symptoms. This polythetic approach reflects clinical reality during the acute post-trauma phase: acute presentations are highly fluid, dynamic, and variable, with one patient displaying predominant dissociation and numbing, while another presents with overwhelming autonomic hyperarousal and relentless intrusive memories. Both patients can achieve the requisite nine-symptom threshold, granting clinicians diagnostic flexibility during crisis evaluations.

In sharp contrast, the diagnostic architecture of Post-Traumatic Stress Disorder mandates strict categorical thresholds across four independent symptom clusters. A clinician evaluating an individual for PTSD cannot simply tally an aggregate score; rather, the patient must meet specific minimum symptom quotas within every single cluster without exception: at least one intrusion symptom from Cluster B; at least one avoidance symptom from Cluster C; at least two negative alterations in cognitions and mood from Cluster D; and at least two arousal and reactivity symptoms from Cluster E. This categorical stringency ensures that an individual cannot receive a PTSD diagnosis based solely on severe depression and hyperarousal without active avoidance, nor can they qualify based on intrusive memories and avoidance without demonstrable neurovegetative and cognitive-affective alterations. The architectural framework of PTSD requires proof of pervasive, systemic multidimensional pathology across all domains of psychological functioning.

Furthermore, the degree of diagnostic emphasis placed on dissociative phenomena reflects a key evolutionary point in nosological development. When ASD was introduced in DSM-IV, it was anchored to the mandatory presence of dissociative symptoms (requiring at least three of five dissociative features, such as numbing, detachment, derealization, depersonalization, or dissociative amnesia), under the hypothesis that acute dissociation was the primary engine driving long-term chronicity. Subsequent empirical studies invalidated this assumption, demonstrating that many patients who developed chronic PTSD did not experience acute dissociation, while many who experienced transient peritraumatic dissociation recovered uneventfully. Consequently, DSM-5-TR decentralized dissociation within ASD, placing it within the fourteen-symptom pool. Within PTSD, dissociation was similarly refined: while dissociative amnesia remains an option in Cluster D, prominent depersonalization and derealization were removed from core criteria and relocated to an independent, highly characterized Dissociative Subtype.

4.3 Epidemiology, Prevalence, and Vulnerability Profiles

The epidemiological profiles of Acute Stress Disorder and Post-Traumatic Stress Disorder reveal marked variations that depend on the nature, severity, and intentionality of the qualifying traumatic event. Across general population surveys, the lifetime prevalence of PTSD in the United States is estimated at approximately 6% to 8%, with higher rates observed among women (roughly 8% to 10%) compared to men (approximately 4%). In contrast, population-wide lifetime prevalence rates for Acute Stress Disorder are rarely calculated, as ASD represents a transient, situational reaction rather than an enduring psychiatric disorder. Instead, epidemiological investigations evaluate the incidence of ASD within specific trauma-exposed cohorts during the immediate 30-day post-trauma window. These investigations reveal wide variations in acute prevalence: following motor vehicle collisions, ASD rates range between 13% and 21%; following severe industrial or accidental burn injuries, rates range from 10% to 33%; and following interpersonal violence, such as aggravated assault, mass shootings, or sexual assault, acute ASD prevalence rates escalate dramatically, reaching 50% or higher.

Vulnerability profiles also diverge when assessing the predictive power of acute symptomatology across diverse demographic and clinical populations. While younger age, female sex, lower socioeconomic status, and pre-existing psychiatric morbidity lower the threshold for developing both ASD and PTSD, the presence of an acute ASD diagnosis exhibits varying predictive validity for chronicity. In civilian trauma populations characterized by single-incident, accidental traumas (such as transportation accidents), the absence of an ASD diagnosis within the first month has a high negative predictive value—meaning that individuals who do not develop ASD are unlikely to develop subsequent PTSD. However, in military combat deployments, civilian humanitarian disasters, or chronic domestic violence settings, the negative predictive value of ASD declines precipitously; in these populations, many individuals who display sub-clinical acute reactions eventually develop chronic, delayed-expression PTSD as chronic stressors erode psychological resilience.

Sociodemographic factors and trauma typology further moderate the trajectory from acute distress to chronic pathology. Traumatic events that are intentional, malicious, and interpersonal in nature—such as sexual assault, combat, torture, or active shooter encounters—exhibit significantly higher conversion rates from ASD to PTSD compared to non-intentional, accidental, or natural disasters. The deliberate violation of human bodily integrity and trust undermines fundamental cognitive schemas of safety, precipitating severe negative alterations in cognitions and mood that resist natural extinction. Furthermore, post-trauma environmental factors—including secondary victim-blaming, severe financial strain, lack of social support, and medical complications—exert a compounding effect, converting what might have been a transient acute stress response into an intractable case of chronic PTSD.

4.4 Treatment Paradigms: Crisis Stabilization vs. Trauma Reprocessing

The clinical interventions indicated for Acute Stress Disorder and Post-Traumatic Stress Disorder diverge sharply, reflecting their contrasting neurobiological stages and clinical objectives. The primary objective during the acute ASD window (Days 3 to 30) is crisis stabilization, mitigation of acute autonomic arousal, restoration of physical and psychological safety, and prevention of maladaptive fear consolidation. Front-line interventions during this phase emphasize Psychological First Aid (PFA), a non-intrusive, supportive framework designed to assess immediate physiological needs, provide compassionate comfort, foster practical problem-solving, and reconnect the survivor with functional family and community support networks. When psychological symptoms meet full ASD criteria, evidence-based guidelines recommend brief, structured trauma-focused cognitive behavioral therapy (TF-CBT). Early TF-CBT typically consists of four to five sessions incorporating psychoeducation, cognitive restructuring of unrealistic guilt or self-blame, gentle exposure to avoided situations, and somatic calming techniques.

Conversely, established Post-Traumatic Stress Disorder requires comprehensive, intensive trauma reprocessing aimed at restructuring deeply consolidated fear networks, modifying catastrophic trauma-related schemas, and promoting fear-extinction learning. First-line gold-standard psychotherapies for PTSD include Prolonged Exposure (PE), developed by Edna Foa, which systematically utilizes in vivo exposure (confronting safe, trauma-avoided situations) and imaginal exposure (repeatedly revisiting the detailed trauma memory in a safe therapeutic environment) to achieve emotional habituation and memory integration. Parallel to PE, Cognitive Processing Therapy (CPT), developed by Patricia Resick, focuses on identifying and challenging catastrophic “stuck points”—distorted beliefs regarding safety, trust, power, esteem, and intimacy stemming from the trauma. Additionally, Eye Movement Desensitization and Reprocessing (EMDR) utilizes dual-attention bilateral sensory stimulation to facilitate the neurocognitive reprocessing of traumatic memories. These intensive therapeutic protocols are contraindicated in the acute peritraumatic phase, as forcing an acutely destabilized individual to undergo deep emotional reprocessing before achieving baseline stabilization can exacerbate traumatic distress.

Pharmacological paradigms similarly display sharp divergence across the two disorders. In the treatment of Acute Stress Disorder, pharmacotherapy is generally discouraged as a primary intervention. Most critically, the administration of benzodiazepines in the acute wake of trauma is strongly contraindicated; neurobiological and clinical studies demonstrate that benzodiazepines disrupt natural fear extinction learning, interfere with normal memory consolidation, and are associated with increased rates and severity of chronic PTSD. In contrast, the pharmacological management of established PTSD includes evidence-based options: the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine hold formal regulatory approval for chronic PTSD, demonstrating clinical efficacy in dampening amygdalar hyper-reactivity, alleviating depressive comorbidity, and stabilizing neurovegetative symptoms. Furthermore, the alpha-1 adrenergic receptor antagonist prazosin is widely deployed in PTSD to cross the blood-brain barrier and block central noradrenergic signaling, effectively mitigating trauma-related nightmares and fragmented sleep architecture.

5. Similarities and Phenomenological Overlap

5.1 Identical Criterion A Exposure Requirements

Despite their nosological divergences and temporal boundaries, Acute Stress Disorder and Post-Traumatic Stress Disorder share a common etiological denominator: the prerequisite of exposure to an identical standard of traumatic severity operationalized under Criterion A in the DSM-5-TR. Both conditions explicitly reject everyday stressors—such as divorce, job loss, romantic dissolution, or standard financial hardship—as qualifying triggers, categorizing the psychological reactions to such life difficulties under Adjustment Disorders. To satisfy the Criterion A prerequisite for either ASD or PTSD, an individual must be exposed to actual or threatened death, serious physical injury, or sexual violence. This diagnostic parity ensures that both conditions are conceptualized as psychiatric reactions emerging from catastrophic threats that challenge fundamental biological survival systems.

Furthermore, both diagnostic entities utilize an identical definition regarding the permissible modes of traumatic exposure. Under both ASD and PTSD frameworks, qualifying trauma exposure must occur through one of four operational pathways: direct personal experience; in-person witnessing of the event as it befalls others; learning that a violent or accidental catastrophic event occurred to a close family member or intimate personal friend; or experiencing repeated or extreme indirect occupational exposure to aversive details of critical incidents. The explicit exclusion of non-occupational exposure via electronic media, television broadcasts, or internet video feeds applies uniformly across both conditions. This identical diagnostic threshold reflects clinical consensus that whether a stress response resolves in three weeks or persists for three decades, its initial neurobiological mobilization is triggered by external stressors capable of overwhelming baseline homeostatic defenses.

This shared etiological threshold serves as a critical clinical safeguard. By anchoring both ASD and PTSD to an objective standard of catastrophic life events, modern psychiatric classification prevents diagnostic dilution. Clinicians are required to establish that a patient’s presenting constellation of hyperarousal, avoidance, and intrusive thoughts originated from an authentic traumatic encounter, rather than general ambient distress. However, it also presents a clinical challenge: because the objective severity of a traumatic stressor does not linearly predict whether an individual will develop ASD, develop PTSD, or achieve spontaneous resilience, clinicians cannot rely on the traumatic event alone to formulate a diagnosis, necessitating careful psychometric evaluation of the survivor’s subsequent psychological processing.

5.2 Symptom Congruence Across Core Domains

The phenomenological overlap between Acute Stress Disorder and Post-Traumatic Stress Disorder is profound, with both conditions sharing core symptomatic manifestations across neurocognitive, behavioral, and neurovegetative domains. In the domain of re-experiencing and intrusion, both ASD and PTSD patients experience unbidden, distressing memories of the trauma that breach conscious awareness with distressing clarity. In both conditions, these memories can escalate into dissociative flashback episodes, wherein situational awareness of the current safe environment is temporarily lost, and the patient acts, feels, and responds as though the catastrophic event were actively recurring. Furthermore, both cohorts exhibit marked physiological cue reactivity: exposure to internal sensory recollections or external environmental triggers resembling the trauma initiates immediate autonomic arousal, manifesting as tachycardia, diaphoresis, dyspnea, and motor tremors.

Behavioral avoidance functions as an identical diagnostic pillar across both clinical presentations. Individuals suffering from either ASD or PTSD engage in deliberate, continuous efforts to evade trauma-related thoughts, feelings, and internal dialogues. Simultaneously, they exhibit pronounced behavioral avoidance directed toward external reminders: they alter daily transportation routes to avoid accident sites, refuse to converse with witnesses, abandon occupational responsibilities, and avoid social environments that arouse memories of the incident. While this avoidance provides temporary reduction of acute anxiety, in both ASD and PTSD it acts as the primary behavioral mechanism maintaining pathology, preventing natural fear extinction and reinforcing the cognitive assumption that the trauma-related stimuli are inherently dangerous.

Finally, both disorders share severe neurovegetative hyperarousal and persistent disruptions of sleep architecture. Patients presenting with either condition display constant hypervigilance, surveying their surroundings for threat, positioning themselves in defensive postures, and reacting with exaggerated startle responses to benign sensory stimuli, such as a door closing or an unexpected loud noise. Severe sleep disturbance is virtually ubiquitous across both cohorts, characterized by prolonged sleep onset latency, frequent nocturnal awakenings driven by adrenergic surges, and terrifying trauma-related nightmares. In both acute and chronic phases, this severe sleep disruption impairs prefrontal cortical processing, further compromising executive emotional regulation and entrenching the traumatic stress syndrome.

5.3 Shared Cognitive Distortions and Functional Impairment

Both Acute Stress Disorder and Post-Traumatic Stress Disorder induce significant restructuring of an individual’s cognitive architecture, generating pervasive, maladaptive cognitive distortions that undermine emotional stability. Traumatic exposure shatters baseline cognitive assumptions regarding safety, predictability, fairness, and personal agency. In both acute and chronic cohorts, patients develop severe, distorted causal attributions regarding the traumatic event, leading to profound survivor guilt and self-blame. Traumatized individuals frequently engage in hindsight bias, convincing themselves that they should have foreseen, prevented, or managed the catastrophic event more effectively, which fuels persistent feelings of shame, humiliation, and self-directed anger.

Moreover, both conditions foster catastrophic misinterpretations of normal psychological and somatic sensations. Following trauma, patients often interpret their own acute stress symptoms—such as crying spells, tachycardia, or intrusive images—as proof that they are “losing their mind” or experiencing irreversible nervous system damage. This secondary catastrophic appraisal amplifies the primary traumatic distress, creating a self-reinforcing loop of anxiety and physiological panic. In both ASD and PTSD, this cognitive shift manifests as a foreshortened future outlook, characterized by an inability to envision long-term career goals, marriage, children, or a normal lifespan, leading to profound demoralization and anhedonia.

The functional impairment produced by both conditions across occupational, social, and interpersonal spheres is severe and clinically equivalent during their respective timeframes. In the acute window of ASD, an affected individual may become completely incapacitated, unable to return to work, care for dependent children, operate a motor vehicle, or engage in basic activities of daily living due to paralyzing panic, confusion, or dissociative detachment. In chronic PTSD, this impairment solidifies into long-term disability, frequently precipitating career abandonment, financial collapse, marital dissolution, and social withdrawal. Furthermore, both patient populations display high secondary vulnerability to comorbid major depressive episodes and frequently resort to maladaptive coping mechanisms, notably the misuse of alcohol, sedatives, or illicit substances to suppress chronic autonomic hyperarousal and intrusive memories.

6. Clinical Decision-Making: When Each Diagnosis Applies

6.1 Assessment Timelines and Differential Diagnostic Flowcharts

Clinical decision-making in the immediate and intermediate aftermath of trauma requires adherence to assessment timelines and structured differential diagnostic flowcharts. When evaluating an acutely traumatized patient, the clinician must first determine the precise chronological interval that has elapsed since the termination of the qualifying Criterion A event. The clinical diagnostic flowchart navigates three distinct temporal epochs:

• The First 72 Hours (Day 0 to Day 3):

  During this immediate peritraumatic window, formal diagnosis of either Acute Stress Disorder or Post-Traumatic Stress Disorder is clinically prohibited under DSM-5-TR guidelines. Clinicians must classify clinical presentations during this phase as normative peritraumatic distress or acute stress reactions. The primary clinical objective is to differentiate expected autonomic arousal and emotional shock from life-threatening medical instability, traumatic brain injury, substance intoxication, or acute psychiatric crises (such as active suicidality or severe psychotic decompensation). Clinical management focuses on Psychological First Aid, medical triage, and safety restoration, without applying formal psychiatric diagnostic labels.

• Day 3 to Day 30 Post-Exposure (The ASD Diagnostic Window):

  Between 72 hours and one month following trauma exposure, the diagnostic criteria for Acute Stress Disorder become operationally active. Clinicians must administer structured screening instruments and clinical interviews to evaluate whether the patient exhibits at least nine of the fourteen DSM-5-TR symptoms across the intrusion, negative mood, dissociation, avoidance, and arousal domains. If the patient satisfies this threshold, exhibits clinically significant functional impairment, and has no confounding substance or medical etiologies, an ASD diagnosis is assigned. This diagnostic assignment alerts the clinical team to deploy early trauma-focused cognitive behavioral interventions and schedule rigorous longitudinal follow-up.

• Day 31 and Onward (The PTSD Diagnostic Threshold):

  At the 30-day post-trauma mark, the diagnostic status of the patient must be systematically re-evaluated. If the patient was previously diagnosed with ASD and their symptoms have significantly attenuated or resolved, the diagnosis is marked as in remission. If, however, the patient continues to exhibit severe symptoms that satisfy the four distinct DSM-5-TR cluster requirements (at least one B, one C, two D, and two E symptoms) with persistent functional impairment, the diagnosis of Acute Stress Disorder is terminated and replaced by Post-Traumatic Stress Disorder. Furthermore, patients presenting for initial clinical evaluation months after a trauma who have never received an ASD evaluation are assessed directly for PTSD, including assessment for the Delayed Expression specifier if full criteria were met only at or beyond the six-month mark.

6.2 Assessment Tools and Validated Psychometric Instruments

The operationalization of trauma-related diagnostic criteria requires validated psychometric assessment tools. During the early post-trauma phase (Days 3 to 30), clinicians deploy screening and diagnostic instruments designed to evaluate acute symptoms. The Acute Stress Disorder Scale (ASDS), developed by Richard Bryant and colleagues, represents a validated 19-item self-report questionnaire that maps directly onto DSM criteria, measuring the severity of acute intrusive, dissociative, avoidance, and arousal symptoms, and serving as a reliable predictor of subsequent PTSD development. Additionally, structured clinical interviews such as the Mini-International Neuropsychiatric Interview (Mini-CIDI) incorporate dedicated modules that allow clinicians to establish formal categorical ASD diagnoses while screening for common comorbid presentations, such as major depressive episodes or acute panic disorder.

For evaluating established Post-Traumatic Stress Disorder (Day 31 and beyond), the undisputed gold standard in clinical research and comprehensive psychiatric assessment is the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), developed by the National Center for PTSD. The CAPS-5 is a comprehensive, 30-item structured clinical interview that systematically interrogates each individual DSM-5-TR Criterion A through Criterion H requirement. For each symptom item, the clinician rates both frequency and intensity on anchored operational scales, evaluates symptom onset and duration, interrogates the specific attribution of the symptom to the index trauma, assesses functional impairment, and evaluates for the presence of the Dissociative Subtype. The CAPS-5 provides diagnostic classification alongside a continuous dimensional severity score, making it the definitive diagnostic benchmark.

In routine clinical practice, primary care settings, and high-volume trauma clinics where long structured interviews may be logistically unfeasible, self-report psychometric monitoring is facilitated by the PTSD Checklist for DSM-5 (PCL-5). The PCL-5 is a 20-item self-report instrument that quantifies the severity of each individual DSM-5-TR symptom on a 5-point Likert scale (ranging from 0 = “Not at all” to 4 = “Extremely”). A total score of 31 to 33 or higher typically indicates probable PTSD requiring formal clinical evaluation. The PCL-5 is valuable for longitudinal measurement-based care, allowing clinicians to track symptomatic shifts from the acute phase across the trajectory of psychotherapy, providing objective data on treatment response, symptom non-response, or post-traumatic recovery.

6.3 Preventative Interventions During the ASD Window

The identification of Acute Stress Disorder provides a critical, time-limited clinical window for deploying preventative interventions designed to disrupt fear memory consolidation and prevent progression into chronic PTSD. The gold-standard, evidence-based intervention during this acute phase is brief Trauma-Focused Cognitive Behavioral Therapy (TF-CBT). Multiple randomized controlled trials have demonstrated that a brief course of TF-CBT (typically four to five weekly sessions) administered during the first two to four weeks post-trauma significantly reduces the rate of subsequent PTSD development compared to supportive counseling or waitlist controls. This early TF-CBT protocol combines psychoeducation regarding normal post-trauma reactions, gentle cognitive appraisal of guilt and catastrophic assumptions, controlled imaginal and in vivo exposure to non-dangerous trauma reminders, and behavioral pacing to re-establish normal routines.

Conversely, historical and psychiatric literature underscores clear clinical contraindications regarding universal psychological debriefing, such as Critical Incident Stress Debriefing (CISD). Throughout the 1980s and 1990s, single-session group debriefings were routinely mandated for entire cohorts of trauma-exposed individuals (such as disaster workers or bank robbery victims) within 24 to 72 hours of an event, encouraging them to comprehensively describe their emotional distress and sensory memories. Rigorous meta-analyses and systematic reviews have conclusively demonstrated that universal psychological debriefing is ineffective and, in some instances, clinically harmful. Forcing an acutely traumatized individual into early emotional processing before their autonomic system has stabilized can heighten autonomic arousal, disrupt natural coping mechanisms, and paradoxically increase the risk of developing chronic PTSD. Consequently, professional clinical guidelines explicitly advise against compulsory, single-session psychological debriefing, reserving structured trauma-focused psychotherapy exclusively for individuals who exhibit demonstrable clinical pathology (such as confirmed ASD).

Preventative strategies during the ASD window also require vigilance regarding sleep hygiene and physiological stabilization. Traumatic sleep disturbance, particularly severe insomnia and repetitive trauma nightmares, severely compromises prefrontal cortical function and facilitates the over-consolidation of traumatic memories. Implementing behavioral sleep interventions—such as establishing dark, quiet sleep environments, restricting stimulants, and structuring bedtime routines—is an essential preventative measure. Furthermore, clinicians must enforce strict pharmacological precautions: the routine prescription of benzodiazepines (such as lorazepam, alprazolam, or clonazepam) for acute distress and sleep disruption must be avoided. Benzodiazepine administration during the acute post-trauma phase inhibits GABA-mediated extinction learning circuits, diminishes endogenous emotional processing, and correlates with increased long-term PTSD incidence, making non-pharmacological stabilization the standard of care.

6.4 Therapeutic Approaches for Established PTSD

When post-traumatic psychopathology escapes early resolution and consolidates into established Post-Traumatic Stress Disorder beyond the one-month mark, the treatment paradigm shifts from acute crisis stabilization to comprehensive trauma reprocessing and long-term neurocognitive rehabilitation. First-line clinical practice guidelines universally endorse manualized trauma-focused psychotherapies as the most effective treatments for established PTSD. Among these, Prolonged Exposure (PE) systematically dismantles post-traumatic avoidance networks through graduated, controlled exposure paradigms. Patients engage in repeated, detailed imaginal exposure—revisiting the primary traumatic memory in the present tense, out loud, within the safety of the therapeutic setting—followed by targeted emotional processing. Concurrently, in vivo exposure assignments guide the patient to confront safe, everyday situations that they have avoided due to trauma-related fear (such as driving, entering crowded spaces, or wearing specific clothing). Through repeated, unreinforced confrontation with these cues, the patient achieves emotional habituation, disrupts conditioned fear responses, and updates their subcortical threat circuitry.

Parallel in efficacy to PE is Cognitive Processing Therapy (CPT), an evidence-based cognitive therapy that focuses on the conceptual landscape of traumatic memory. CPT operates on the premise that PTSD is maintained by distorted, catastrophic cognitive appraisals, termed “stuck points,” regarding the trauma’s causes, consequences, and implications for one’s life. The therapist guides the patient through Socratic questioning to identify and challenge distortions surrounding self-blame, survivor guilt, and overgeneralized beliefs that the world is entirely malevolent or that the self is permanently broken. By systematically evaluating evidence and generating balanced cognitions across core life themes (safety, trust, power and control, esteem, and intimacy), CPT reorganizes the patient’s narrative memory and resolves post-traumatic distress. Similarly, Eye Movement Desensitization and Reprocessing (EMDR) facilitates the adaptive resolution of traumatic memories by having the patient access traumatic imagery and negative self-cognitions while engaging in sets of bilateral visual saccades or tactile cues, stimulating associative memory processing and lowering emotional intensity.

When psychotherapy is unavailable, declined, or yields incomplete clinical remission, evidence-based pharmacotherapies play a vital role in established PTSD management. The selective serotonin reuptake inhibitors sertraline and paroxetine represent the primary medications holding regulatory approval for PTSD, with the off-label deployment of fluoxetine and the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine also supported by clinical trial evidence. These agents modulate monoaminergic neurotransmission across corticolimbic networks, mitigating autonomic hyperarousal, reducing intrusive memories, and addressing depressive comorbidity. As an adjunctive pharmacological strategy, the centrally acting alpha-1 adrenergic antagonist prazosin is commonly utilized off-label to cross the blood-brain barrier and block hyperactive noradrenergic signaling at postsynaptic receptors, reducing trauma-related nightmares and improving sleep continuity. In treatment-resistant presentations, neuromodulation strategies—such as repetitive transcranial magnetic stimulation (rTMS) directed toward the dorsolateral prefrontal cortex—and intensive trauma-focused residential programs are increasingly deployed to restore psychological functioning.

7. Frequently Asked Questions

7.1 Does an Acute Stress Disorder Diagnosis Inevitably Progress to PTSD?

An Acute Stress Disorder diagnosis does not inevitably progress to Post-Traumatic Stress Disorder. While ASD represents a major clinical risk factor for subsequent chronic pathology, extensive empirical studies demonstrate that approximately 50% of individuals diagnosed with ASD experience spontaneous symptom remission, or complete recovery following brief early intervention, within the first thirty days post-exposure. The human central nervous system possesses innate psychological and neurobiological resilience mechanisms that facilitate the gradual processing, extinction, and contextualization of traumatic fear memories once physical safety has been secured. When an individual is supported by strong psychosocial resources, safe living environments, compassionate validation, and structured early coping strategies, the acute corticolimbic destabilization characteristic of ASD often settles, returning the autonomic nervous system to baseline homeostasis.

The trajectory from ASD to PTSD is heavily governed by the presence or absence of compounding risk and protective factors. Protective factors include rapid access to social support, high pre-trauma cognitive reserve, absence of severe secondary financial or legal stressors, and the early implementation of brief trauma-focused cognitive behavioral therapy. Conversely, progression toward chronic PTSD is significantly more likely in individuals who experience severe, unremitting peritraumatic dissociation, persistent insomnia, unaddressed traumatic brain injuries, comorbid major depressive episodes, or lack of social validation. Therefore, a clinical diagnosis of ASD should be conceptualized not as an unavoidable life sentence of chronic psychiatric illness, but rather as an urgent clinical alert that identifies an individual requiring systematic monitoring, supportive crisis stabilization, and early targeted intervention to prevent chronicity.

7.2 Can PTSD Be Diagnosed Without an Initial Acute Stress Disorder Phase?

Post-Traumatic Stress Disorder can be, and frequently is, diagnosed in individuals who never met the diagnostic criteria for Acute Stress Disorder during the initial month following trauma exposure. Epidemiological and military psychiatric research indicates that a substantial proportion of patients who ultimately satisfy the diagnostic criteria for chronic PTSD presented with sub-threshold symptoms, or appeared outwardly resilient and functional, during the initial 30-day post-trauma window. This phenomenon occurs through several distinct clinical mechanisms: first, many individuals initially mobilize rigid psychological defenses, intense behavioral avoidance, or complete immersion in operational, professional, or caregiving duties, which masks underlying emotional trauma. When these external structures eventually diminish months later, the underlying traumatic memories resurface, precipitating delayed clinical decompensation.

Second, the DSM-5-TR explicitly recognizes the Delayed Expression specifier for PTSD, which formally accommodates clinical presentations wherein the full diagnostic criteria are not satisfied until at least six months following the traumatic event. In many instances, an individual may navigate the acute post-trauma phase with mild, tolerable stress symptoms that do not meet the nine-symptom requirement for ASD. However, the subsequent occurrence of secondary life stressors—such as divorce, job loss, physical illness, or a secondary minor accident—can exhaust remaining cognitive coping mechanisms, acting as an environmental catalyst that unmasks latent traumatic memories and precipitates full-syndrome PTSD. Consequently, clinicians must never exclude a diagnosis of PTSD simply because an individual demonstrated stable functioning or lacked an ASD diagnosis during the immediate aftermath of a traumatic event.

7.3 What Distinguishes Normal Peritraumatic Stress from Acute Stress Disorder?

The distinction between normal peritraumatic stress and Acute Stress Disorder rests primarily upon symptom severity, functional impairment, and temporal parameters. In the immediate wake of an overwhelming, life-threatening event, experiencing transient neurobiological and psychological distress is a universal human reaction. Normal peritraumatic stress represents a phylogenetically conserved, adaptive mobilization of survival circuits, characterized by transient tachycardia, crying, muscular tension, trembling, acute sadness, disbelief, and difficulty sleeping during the initial 24 to 48 hours. These reactions reflect the physiological shock of confronting danger and do not signify psychopathology; in the vast majority of individuals, these acute stress reactions begin to stabilize once immediate safety is established, routines are resumed, and social support is activated.

In contrast, Acute Stress Disorder is defined by a level of symptom severity, persistence, and functional incapacitation that exceeds normative adaptive boundaries. Clinically, this divergence is governed by three primary criteria: first, the temporal threshold mandates that symptoms must persist for at least three full days post-trauma; transient reactions that resolve within 72 hours are classified as normative peritraumatic distress. Second, the symptom density threshold requires the presence of at least nine severe symptoms across the intrusion, negative mood, dissociation, avoidance, and arousal domains, capturing a state of multidimensional destabilization. Third, and most decisively, ASD requires demonstrable, severe functional impairment: an individual experiencing normal stress can still communicate basic needs, care for themselves, and process simple directions, whereas an individual with ASD is often functionally incapacitated by dissociative detachment, panic attacks, severe cognitive confusion, or paralyzing hyperarousal, rendering them unable to manage daily life.

7.4 Why Are Benzodiazepines Generally Discouraged in the Treatment of ASD and PTSD?

The clinical discouragement and formal guideline contraindication of benzodiazepines in the management of Acute Stress Disorder and Post-Traumatic Stress Disorder are grounded in neurobiological evidence and clinical trials. While benzodiazepines (such as diazepam, lorazepam, alprazolam, and clonazepam) act as positive allosteric modulators at GABA-A receptors and provide rapid, short-term reduction of subjective anxiety and muscle tension, their underlying neurobiological actions directly undermine the essential mechanisms required for natural trauma recovery and fear extinction. The successful resolution of post-traumatic stress requires the central nervous system to engage in fear extinction learning—a process heavily dependent on NMDA receptor-mediated glutamatergic plasticity within the amygdala and medial prefrontal cortex. By potentiating inhibitory GABAergic transmission, benzodiazepines blunt this plasticity, preventing the brain from encoding the memory that trauma-related cues are no longer dangerous.

Furthermore, clinical and observational studies have linked early benzodiazepine administration in the immediate wake of trauma to increased rates and heightened severity of subsequent PTSD. Patients administered benzodiazepines following critical incidents display higher rates of intrusive memories and avoidance behaviors at longitudinal follow-up compared to those receiving non-pharmacological care or placebo. Beyond disrupting fear extinction, benzodiazepines present significant clinical risks in traumatized populations, including the rapid development of physiological tolerance, physical dependence, severe rebound anxiety and insomnia upon discontinuation, and behavioral disinhibition. Given that individuals with trauma-related disorders exhibit high rates of secondary substance use disorders, introducing addictive sedative-hypnotic agents creates an elevated risk for comorbid substance dependence, leading major psychiatric bodies to recommend against their deployment in both acute and chronic trauma contexts.

8. Conclusion

8.1 Summary of Core Distinctions and Shared Pathology

The clinical and nosological distinction between Acute Stress Disorder and Post-Traumatic Stress Disorder represents an important framework within modern trauma psychiatry. Both conditions are united by a common etiological foundation: the exposure to actual or threatened death, serious physical injury, or sexual violence under the strict criteria of Criterion A. Both disorders exhibit marked phenomenological convergence, manifesting as unprompted intrusive memories, dissociative flashbacks, severe autonomic cue reactivity, pervasive behavioral avoidance of trauma reminders, disruptive sleep pathology, and profound cognitive alterations regarding safety and self-worth. These shared manifestations highlight that both ASD and PTSD represent manifestations of an overburdened fear-processing apparatus responding to life-threatening danger.

However, the boundaries separating these conditions remain clinically definitive. Temporally, Acute Stress Disorder is restricted to the acute post-trauma phase, requiring symptoms to endure between three days and one month post-exposure, whereas Post-Traumatic Stress Disorder is diagnosed only when symptoms persist beyond the one-month mark, often running an unremitting course if left untreated. Structurally, the DSM-5-TR operationalizes ASD through a flexible, polythetic checklist requiring at least nine of fourteen symptoms across five functional areas, reflecting the fluid nature of acute post-traumatic crises, while PTSD mandates a rigorous categorical threshold requiring minimum symptom counts across four distinct clusters. Furthermore, their international nosology reflects conceptual divergence: while the DSM-5-TR treats ASD as an acute mental disorder, the WHO’s ICD-11 classifies acute post-traumatic distress as a non-pathological, transient Acute Stress Reaction. Early clinical identification, temporal tracking, and the deployment of appropriate phase-specific interventions—crisis stabilization for ASD, and trauma reprocessing for PTSD—remain essential for mitigating long-term psychiatric disability.

8.2 Future Directions in Traumatic Stress Research

The landscape of traumatic stress research is rapidly evolving, driven by innovations in molecular psychiatry, functional neuroimaging, digital health, and novel neuroplasticity-enhancing therapeutics. A major research frontier centers on the identification of objective biological and genetic biomarkers capable of predicting which individuals with Acute Stress Disorder will achieve spontaneous remission and which will transition to chronic PTSD. Emerging research is investigating peripheral microRNA expressions, neuroinflammatory cytokine panels, autonomic pupillometry metrics, and functional connectivity patterns within corticolimbic resting-state networks to develop algorithmic risk-stratification models. In tandem with biological markers, the advent of digital phenotyping—utilizing wearable physiological sensors and smartphone-based tracking of sleep architecture, heart rate variability, and passive mobility patterns—promises real-time, objective surveillance of peritraumatic recovery, enabling stepped-care clinical interventions before maladaptive memory consolidation solidifies.

Concurrently, the therapeutic landscape for post-traumatic conditions is undergoing a clinical paradigm shift through the investigation of novel pharmacological agents designed to enhance psychotherapeutic efficacy. Most prominently, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy has demonstrated clinical efficacy in late-stage Phase 3 clinical trials for moderate-to-severe, chronic, treatment-resistant PTSD. MDMA acts by stimulating the release of serotonin, dopamine, and norepinephrine while elevating levels of oxytocin and brain-derived neurotrophic factor (BDNF). This unique neurochemical profile reduces amygdalar threat reactivity, promotes emotional empathy, and enhances fear extinction learning, allowing patients to revisit and reprocess traumatic memories without being overwhelmed by hyperarousal or dissociative detachment. As these and other neuroplasticity-enhancing agents (such as ketamine and targeted neurofeedback) undergo rigorous investigation, the future of trauma psychiatry holds significant promise for personalized, biologically informed interventions capable of interrupting the trajectory from acute traumatic shock to lifelong psychological impairment.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425596

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders: Text revision (5th ed., text rev.). American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425787

Bryant, R. A. (2011). Acute stress disorder as a predictor of posttraumatic stress disorder: A systematic review. The Journal of Clinical Psychiatry, 72(2), 233–239. https://doi.org/10.4088/JCP.09r05072blu

Bryant, R. A., Moulds, M. L., & Guthrie, R. M. (2000). Acute Stress Disorder Scale: A self-report measure of acute stress reactions. Psychological Assessment, 12(1), 61–68. https://doi.org/10.1037/1040-3590.12.1.61

Foa, E. B., Hembree, E. A., & Rothbaum, B. O. (2007). Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences therapist guide. Oxford University Press.

Horowitz, M. J. (1976). Stress response syndromes. Jason Aronson.

Lanius, R. A., Brand, B., Vermetten, E., Frewen, P. A., & Spiegel, D. (2012). The dissociative subtype of posttraumatic stress disorder: Rationale, clinical and neurobiological evidence, and implications for DSM-5. Depression and Anxiety, 29(8), 701–708. https://doi.org/10.1002/da.21889

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Carr, A., Quevedo, M., Lucas, G., DellaCrosse, M., Hamilton, S., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025–1033. https://doi.org/10.1038/s41591-021-01336-3

Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Holmes, A., Hoff, D., Hart, K., Holmes, T., Thomas, D., Kakuma, T., & Radant, A. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. The New England Journal of Medicine, 378(6), 507–517. https://doi.org/10.1056/NEJMoa1507598

Resick, P. A., Monson, C. M., & Chard, K. M. (2016). Cognitive processing therapy for PTSD: A comprehensive manual. Guilford Press.

Shalev, A. Y., Ankri, Y., Israeli-Shalev, Y., Peleg, T., Adessky, R., & Freedman, S. (2012). Prevention of posttraumatic stress disorder by early treatment: Results from the Jerusalem Trauma Outreach and Prevention study. Archives of General Psychiatry, 69(2), 166–176. https://doi.org/10.1001/archgenpsychiatry.2011.127

Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486

World Health Organization. (2019). International statistical classification of diseases and related health problems (11th ed.). World Health Organization. https://icd.who.int/

Yehuda, R., Hoge, C. W., McFarlane, A. C., Vermetten, E., Lanius, R. A., Nievergelt, C. M., Hobfoll, S. E., Beekman, A. T., Jairam, R., & Hyman, S. E. (2015). Post-traumatic stress disorder. Nature Reviews Disease Primers, 1, Article 15057. https://doi.org/10.1038/nrdp.2015.57